Literature DB >> 12715893

Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.

Nadia Al-Fakhri1, Triantafyllos Chavakis, Thomas Schmidt-Wöll, Bei Huang, Sanjay M Cherian, Yuri V Bobryshev, Reginald S A Lord, Norbert Katz, Klaus T Preissner.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) and two-chain high molecular weight kininogen (HKa) exert anti-adhesive properties in vitronectin-dependent cell adhesion. Here, the hypothesis was tested that these anti-adhesive components promote apoptosis in vascular cells. PAI-1 or HKa induced a 2- to 3-fold increase in apoptosis of human umbilical-vein endothelial cells (HUVEC) and vascular smooth muscle cells (VSMC) adherent to vitronectin, as determined by annexin V-FACS assay, similar to alphav-integrin inhibitor cyclo-(Arg-Gly-Asp-D-Phe-Val)-peptide (cRGDfV). Apoptosis occurred after 12 h incubation and was attributable to caspase 3 activation that in turn induced DNA fragmentation. Induction of apoptosis strongly correlated with the anti-adhesive effect of PAI-1 and HKa on these cells. In contrast, PAI-1 and HKa did not affect fibronectin-dependent adhesion or cell survival. uPA did not influence apoptosis in vitronectin- or fibronectin-adherent cells. In atherosclerotic vessel sections, congruent distribution of vitronectin, PAI-1, HK, and of components of the urokinase plasminogen activator/receptor system with apoptotic cells lining foam cell lesions was demonstrated by immunostaining. These results indicate that inhibition of vitronectin-dependent cell adhesion through PAI-1 and HKa correlates with apoptosis induction in vascular cells mediated through the caspase 3 pathway. Co-distribution of apoptosis with plasminogen activation system components in atherosclerosis exemplifies the significance of anti-adhesive mechanisms and apoptosis for tissue remodeling, such as in neointima development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715893     DOI: 10.1515/BC.2003.048

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  17 in total

1.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

2.  Zebra Tail Amplification: Accelerated Detection of Apoptotic Blunt-Ended DNA Breaks by In Situ Ligation.

Authors:  Vladimir V Didenko
Journal:  Methods Mol Biol       Date:  2017

3.  In situ ligation simplified: using PCR fragments for detection of double-strand DNA breaks in tissue sections.

Authors:  Vladimir V Didenko
Journal:  Methods Mol Biol       Date:  2011

4.  Inhibition of neutrophil apoptosis by PAI-1.

Authors:  Jaroslaw W Zmijewski; Hong-Beom Bae; Jessy S Deshane; Cynthia B Peterson; David D Chaplin; Edward Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-27       Impact factor: 5.464

5.  Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.

Authors:  Evan Gomes-Giacoia; Makito Miyake; Steve Goodison; Charles J Rosser
Journal:  Mol Cancer Ther       Date:  2013-09-26       Impact factor: 6.261

6.  siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.

Authors:  Yan-ping Zhang; Wen-bin Li; Wei-li Wang; Jian Liu; Shu-xia Song; Lin-lin Bai; Yu-yan Hu; Ya-dong Yuan; Min Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-06-04       Impact factor: 6.150

7.  Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

Authors:  Jianbo Wu; Lin Peng; Grainne A McMahon; Daniel A Lawrence; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-02       Impact factor: 8.311

Review 8.  Plasminogen activator inhibitor-1: the double-edged sword in apoptosis.

Authors:  Rashna D Balsara; Victoria A Ploplis
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

Review 9.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

10.  Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques.

Authors:  P Rossignol; A Luttun; J L Martin-Ventura; F Lupu; P Carmeliet; D Collen; E Anglès-Cano; H R Lijnen
Journal:  J Thromb Haemost       Date:  2006-03       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.